Zymofix, a biotech company based in Ghent, Belgium, has secured €1.9 million in grant funding from VLAIO, the Flemish Agency for Innovation & Entrepreneurship, to support a €3.2 million collaborative research project called MicroFix.
The three-year project will be carried out with Prof. Tina Kyndt from the Faculty of Bioscience Engineering at Ghent University. It will examine how Zymofix’s manufacturing process affects microbial physiology, functional traits and performance in agricultural systems.
The research is centred on the company’s Zyft solid-state fermentation platform and is intended to build a stronger scientific basis for more predictable microbial product performance. The funding will support work to advance solid-state fermentation research and better understand how production methods shape the effectiveness of biological products in agriculture.
For Zymofix, the grant marks a notable step in expanding research around next-generation microorganism production, at a time when agricultural biotech continues to look for more reliable biological alternatives.
The three-year project will be carried out with Prof. Tina Kyndt from the Faculty of Bioscience Engineering at Ghent University. It will examine how Zymofix’s manufacturing process affects microbial physiology, functional traits and performance in agricultural systems.
The research is centred on the company’s Zyft solid-state fermentation platform and is intended to build a stronger scientific basis for more predictable microbial product performance. The funding will support work to advance solid-state fermentation research and better understand how production methods shape the effectiveness of biological products in agriculture.
For Zymofix, the grant marks a notable step in expanding research around next-generation microorganism production, at a time when agricultural biotech continues to look for more reliable biological alternatives.